Medicines | European Medicines Agency

Medicines

For help on how to get the results you want, see our search tips.

Search results

Categories

Medicine name

Active substance / international non-proprietary name (INN) / common name

Medicine

Product number

Patient safety

Authorisation status

ATC code

Marketing authorisation date

Marketing authorisation holder

Pharmacotherapeutic group

Date of opinion

Medicine type

Therapeutic area

Last updated

First published

8 results

Sort by

List item

Human medicine European public assessment report (EPAR): Gilenya (updated)

fingolimod hydrochloride , Multiple Sclerosis
Date of authorisation: 17/03/2011, , , Revision: 28, Authorised, Last updated: 04/02/2021
List item

Human medicine European public assessment report (EPAR): Xarelto (updated)

rivaroxaban, Arthroplasty, Replacement, Venous Thromboembolism
Date of authorisation: 30/09/2008, , , Revision: 33, Authorised, Last updated: 02/02/2021
List item

Human medicine European public assessment report (EPAR): Xeljanz

tofacitinib citrate, Arthritis, Rheumatoid
Date of authorisation: 21/03/2017,
Date of refusal: 25/04/2013, , , Revision: 16, Authorised, Last updated: 28/01/2021
List item

Human medicine European public assessment report (EPAR): Capecitabine Medac

capecitabine, Colorectal Neoplasms
Date of authorisation: 19/11/2012, , , Revision: 10, Authorised, Last updated: 05/08/2020
List item

Human medicine European public assessment report (EPAR): Capecitabine Accord

capecitabine, Colonic Neoplasms, Breast Neoplasms, Colorectal Neoplasms, Stomach Neoplasms
Date of authorisation: 20/04/2012, , , Revision: 12, Authorised, Last updated: 03/08/2020
List item

Human medicine European public assessment report (EPAR): Ecansya (previously Capecitabine Krka)

capecitabine, Colonic Neoplasms, Breast Neoplasms, Colorectal Neoplasms, Stomach Neoplasms
Date of authorisation: 20/04/2012, , , Revision: 12, Authorised, Last updated: 31/07/2020
List item

Human medicine European public assessment report (EPAR): Capecitabine Teva

capecitabine, Colonic Neoplasms, Breast Neoplasms, Colorectal Neoplasms, Stomach Neoplasms
Date of authorisation: 20/04/2012, , , Revision: 13, Authorised, Last updated: 29/07/2020
List item

Human medicine European public assessment report (EPAR): Lemtrada

alemtuzumab, Multiple Sclerosis
Date of authorisation: 12/09/2013, , , Revision: 10, Authorised, Last updated: 21/07/2020